In celebration of STEM Day, the OmniAb Women’s Network for STEM (OWN STEM) had the incredible opportunity to welcome high school students for an up-close experience with OmniAb's high throughput screening tools, including GEM and xPloration®. Together, we’re empowering the next generation of innovators, engineers, scientists, and creators. Thank you to everyone who made this event possible, including our community partners at Berkeley Lab.
OmniAb, Inc.
Biotechnology Research
Emeryville, California 3,607 followers
Access the most diverse antibody repertoires and screening technologies to discover next-generation therapeutics
About us
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.
- Website
-
https://www.omniab.com/
External link for OmniAb, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Emeryville, California
- Type
- Public Company
Locations
-
Primary
5980 Horton Street, Suite 600
Emeryville, California 94608, US
Employees at OmniAb, Inc.
Updates
-
OmniAb’s CEO Matt Foehr joined industry leaders from Gilead, Inimmune, Medable and NVIDIA at the Bio Investor Forum in San Francisco this afternoon for a panel discussion on “AI Productivity Enhancements for Developing Assets.” The panel, moderated by Ruchita Sinha of AV8 Ventures, discussed the importance of AI-related productivity enhancements that leading biotechs are using to discover and develop new drugs. #BIF24
-
We are in Basel this week for the Festival of Biologics! Come see Christel Iffland’s presentation on AI-powered bispecific antibody discovery tomorrow: https://lnkd.in/gdZDuaR7 Our team will be in Booth 822, stop by!
-
We're happy to be back in Boston for Discovery on Target! Visit the OmniAb team at Booth 505 and join us for a luncheon presentation tomorrow at 12:10 pm to hear about our advanced antigen design capabilities. See you there: https://lnkd.in/gAepnNs8 #BostonDOT24
-
We're back in Boston this week for the 9th Annual CAR-TCR Summit! Join us in hearing how cell therapy development is evolving, leading to safer, more efficacious therapeutic options. Find a time to chat with the OmniAb team: https://lnkd.in/gw9Y5jxZ #CARTCR
-
Our team is in Boston this week for the 15th Annual World Bispecific Summit! Join us on Thursday at 10am ET for a presentation with Yasmina Noubia Abdiche as she presents how our engineered animals and AI-assisted single B cell discovery workflows transform bispecific development. https://lnkd.in/gdbyiC6Z
-
OmniAb to Participate in Two Investor Conferences in September https://lnkd.in/gckm8wWr
-
OmniAb, Inc. reposted this
A huge thank you to OmniAb, Inc. for organizing a fantastic hygiene kit assembly event! With the help of 20 dedicated volunteers, we assembled 500 hygiene kits that will make a real difference in our communities. In the Bay Area, these kits will benefit Safe Passages a local non-profit based in Oakland focused on disrupting the cycle of poverty by engaging youth and families to build and drive a continuum of services that supports student success and community development. Together, we're helping to provide essential care to those in need. #togetherwecandomore #lifesciencecares #CommunityImpact #SafePassages
-
OmniAb, Inc. reposted this
OmniAb, Inc. is at the forefront of pharmaceutical innovation, particularly in ion channel drug discovery, thanks to the power of AI. Our new blog, contributed by Nathan Zahler, Ph.D., Senior Informatics Scientist at OmniAb, delves into how OmniAb is leveraging LandingLens to streamline the analysis of high-throughput electrophysiology data, cutting down processing time from 30 minutes to 5. This advancement not only speeds up drug discovery but ensures unparalleled data quality. Learn more about this game-changing approach by reading the full case study: https://lnkd.in/gvb7YwvD #AI #Pharmaceuticals #VisualAI